Tag: Guide

Essential Market Access Resources for Foreign Pharma Companies in China body { font-family: -apple-system, BlinkMacSystemFont, 'Segoe UI', Roboto, san

Essential GMP Compliance Resources for Foreign Pharma Manufacturers in China body { font-family: -apple-system, BlinkMacSystemFont, 'Segoe UI', Roboto

China Patent Law Amendment Review: What It Means for Pharma IP Protection The Fourth Amendment to China's 专利法 (Patent Law, zhuānlì fǎ), effective June

NMPA Priority Review Policy: What It Means for Drug Approvals in China The National Medical Products Administration (NMPA, 国家药品监督管理局, guójiā yàopǐn ji

NRDL 2026 Update Review: What It Means for Foreign Pharma in China The 2026 revision of China’s National Reimbursement Drug List (国家医保目录, National Rei

How Bayer Achieved GMP Compliance in China: Manufacturing Case Study Bayer AG, the German pharmaceutical and life sciences giant, has invested over €1